ArticleScientific reports2026
Screening of wild cicer germplasm from the fertile crescent against four pathotypes of Ascochyta rabiei.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Ascochyta blight is one of the most devastating diseases in chickpea-growing regions. Yield losses due to this disease can reach up to 100% in fields where susceptible genotypes are cultivated. To mitigate these impacts, resistant or tolerant varieties are recommended for effective disease control. However, Ascochyta rabiei, the causal pathogen, has the capacity to evolve into new pathotypes due to its genetic variability. Therefore, identifying novel sources of resistance is crucial for breeding programs. In Türkiye, four distinct pathotypes of Ascochyta rabiei are known, which differ in aggressiveness, with Pathotype IV being the most virulent. In this study, 159 wild accessions of C. reticulatum and C. echinospermum, together with seven C. arietinum genotypes comprising six registered cultivars and one desi-type genotype, were phenotypically screened against four A. rabiei pathotypes to evaluate their resistance responses. Statistical analysis revealed significant differences (p < 0.01) among genotypes in their reactions to the four pathotypes. Furthermore, cluster analysis identified promising genotypes that may serve as potential resistance sources. Among the clusters, C1 exhibited the lowest mean reaction scores, highlighting its promise for breeding purposes. Notably, genotype 592, a C. reticulatum accession collected from Savur, Mardin, demonstrated resistance to all pathotypes, making it a valuable candidate for further research. Future studies will focus on elucidating the genetic background of these promising genotypes to support their integration into breeding programs aimed at enhancing resistance against Ascochyta blight.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.